Medicare Enrolled

Dr. Amit Chakravarty, MD

Pulmonary Disease · Jacksonville, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8075 GATE PKWY W, Jacksonville, FL 32216
9047396666
In practice since 2006 (19 years)
NPI: 1154352326 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chakravarty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chakravarty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chakravarty

Dr. Amit Chakravarty is a pulmonary disease in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Chakravarty performed 2,847 Medicare services across 1,505 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chakravarty received a total of $23,152 from 49 pharmaceutical and/or device companies across 1005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chakravarty is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 19% volume in FL$ $23,152 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,847
Medicare services
Top 19% in FL for pulmonary disease
1,505
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~150 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes764$30$87
Office visit, established patient (30-39 min)580$92$256
Hospital follow-up visit, moderate complexity499$62$143
Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes179$139$329
Inhalation treatment for airway obstruction or sputum production157$7$22
Test to determine lung volumes using gas dilution or washout156$32$86
Test to examine how well the lungs exchange gases156$41$114
Test to measure expiratory airflow and volume changes before and after medication administration155$28$76
Initial hospital admission, high complexity82$135$399
New patient office visit, complex (60-74 min)64$161$447
Nursing facility discharge day management, 30 minutes or less27$64$144
Test for exercise-induced spasm of lung airways17$63$173
Nursing facility discharge management, more than 30 minutes11$103$206
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,152
Total received (2018-2024)
Avg $3,307/year across 7 years
Top 10% in FL for pulmonary disease
49
Companies
1,005
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,021 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,050
2023
$4,017
2022
$6,344
2021
$2,987
2020
$2,359
2019
$1,564
2018
$1,831

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,803
GlaxoSmithKline, LLC.
$2,965
Ethicon Inc.
$2,421
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,958
Grifols USA, LLC
$1,944
Mallinckrodt Hospital Products Inc.
$1,023
Philips Electronics North America Corporation
$982
Actelion Pharmaceuticals US, Inc.
$931
Takeda Pharmaceuticals U.S.A., Inc.
$854
Covidien LP
$757
Inogen, Inc.
$585
GENZYME CORPORATION
$555
United Therapeutics Corporation
$474
Amgen Inc.
$325
Baxter Healthcare
$322
Genentech USA, Inc.
$319
Mylan Specialty L.P.
$288
Sunovion Pharmaceuticals Inc.
$284
ANI Pharmaceuticals, Inc.
$223
INOGEN, INC.
$223
Regeneron Healthcare Solutions, Inc.
$178
Merck Sharp & Dohme LLC
$172
Insmed, Inc.
$151
Medical Device Business Services, Inc.
$127
Electromed, Inc.
$126
Novartis Pharmaceuticals Corporation
$110
Circassia Pharmaceuticals Inc
$102
Inspire Medical Systems, Inc.
$98
Advanced Respiratory, Inc
$96
PFIZER INC.
$82
Paratek Pharmaceuticals, Inc.
$80
Exeltis, USA Inc.
$75
Pulmonx Corporation
$74
Philips North America LLC
$67
CSL Behring
$51
Mallinckrodt LLC
$40
Johnson & Johnson Health Care Systems Inc.
$39
Apria Healthcare LLC
$34
Fisher & Paykel Healthcare Inc
$29
SANOFI US SERVICES INC.
$28
Vifor Pharma, Inc.
$24
Mallinckrodt Enterprises LLC
$23
Merck Sharp & Dohme Corporation
$22
Horizon Therapeutics plc
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Olympus America Inc.
$16
Sandoz Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Gilead Sciences, Inc.
$11
Top 3 companies account for 39.7% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8744) Trilogy Evo · (8874) InCourage · (8874) inCourage · (8944) Trilogy Evo Universal · (9369) Reusable Vest · (AK6) Vest Therapy · 400476/Simplus Full Face Mask- Medium · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · EBUS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · KEYTRUDA · LONHALA MAGNAIR · Life 2000 Ventilation System · Medela · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PAXLOVID · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · RAYOS · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Utibron · VERQUVO · WINREVAIR · XOLAIR · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · Zemaira · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in FL.

Equivalent to $813 per 100 Medicare services performed
Looking for a pulmonary disease in Jacksonville?
Compare pulmonary diseases in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
64
Per 100K population
6.4
County median income
$68,447
Nearest hospital
HCA FLORIDA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chakravarty is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chakravarty experienced with subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes?
Based on Medicare claims data, Dr. Chakravarty performed 764 subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chakravarty receive payments from pharmaceutical companies?
Yes. Dr. Chakravarty received a total of $23,152 from 49 companies across 1,005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chakravarty's costs compare to other pulmonary diseases in Jacksonville?
Dr. Chakravarty's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chakravarty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →